Health authorities are implementing a targeted immunization initiative aimed at protecting one million teenagers and young adults against meningitis B. The programme will offer two doses of the MenB vaccine free on the NHS to Year 13 pupils and individuals under 25 beginning university or residential further education this autumn, with officials noting this population faces elevated risk due to shared living arrangements.
Meningitis is an infection affecting the protective membranes surrounding the brain and spinal cord. While it can develop in any age group, it occurs most frequently in babies, young children, teenagers, and young adults. The condition can be caused by bacteria or viruses, with bacterial forms being rarer but more severe. Meningococcal group B, or MenB, accounts for most cases of invasive meningococcal disease in the UK. According to official data, there were 378 cases of invasive meningococcal disease recorded in 2024-2025.
Symptoms of meningitis develop rapidly and may include a rash that does not fade under pressure, sudden high fever, severe headache, stiff neck, vomiting, diarrhea, joint and muscle pain, light sensitivity, extremely cold extremities, seizures, confusion, and extreme fatigue. The condition requires urgent medical attention, as early treatment can be life-saving.
Meningitis spreads through close personal contact, particularly via respiratory droplets from coughs and sneezes, saliva exchange during kissing, or shared items like drinks and vaping devices. Some individuals carry meningococcal bacteria in their nose or throat without developing illness but can transmit it to others. Disease cases typically peak from October to November annually. Outbreaks, though uncommon, can occur in settings where large numbers congregate, such as university campuses or entertainment venues.
Multiple vaccines provide protection against meningitis causes. The MenB vaccine is recommended for infants beginning at eight weeks old, with additional doses at 12 weeks and one year. Other vaccines including MenACWY, pneumococcal, and combination immunizations also offer protection. Vaccines contain no live bacteria and cannot cause meningitis. Antibiotic treatment given to exposed contacts represents another key prevention measure.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI